The ATP-sensitive K+ channels (KATP) are characterized by strong inhibition by intracellular ATP but their activity is also modulated by various intraand extracellular factors with complicated and undefined mechanism. These factors include a low concentration of ADP (or ATP/ADP ratio), a mildly low pH, G-protein coupled process, adenosine and so on. Intracellular ATP has a ligand action to inhibit the channel activity on the one hand, but on the other ATP is necessary for maintaining the channels in an operative state, probably due to the enzymatic process involving ATP hydrolysis. KATP is inhibited by antidiabetic sulfonylureas and sodium 5-hydroxydecanoate. The channels are activated by the K+ channel openers in an ATP-dependent manner, but may have diverse mechanisms of actions depending on different compounds. The KATP channel openings are responsible for shortening the action potential duration (APD) and partial K+-efflux during early ischemia. The discrepancy between the high sensitivity of intracellular ATP to inhibit KATP in cell-free, inside-out patches and millimolar orders of myocardial ATP concentration determined by the biochemical techniques may cast some doubts on the actual openings of this channel. It can be explained by the presence of cofactors to stimulate channel opening, heterogeneity or compartmentation of ATP distribution in the cell, the properties and high density of KATP, or a combination of these factors. The opening of KATP during ischemia may contribute to the development and aggravation of serious arrhythmias to some extent, but their opening also protects cellular damage, limits infarct size and improves recovery of cardiac function during reperfusion, acting as a cardioprotection mechanism. KATP opening may mimick the effects of ischemic preconditioning, but its effect may be variable among different animal species and experimental conditions. Further studies are necessary to clarify the actual role of channel opening and the molecular mechanism. (Jpn Heart J 1997; 38: 297-315) 
M YOCARDIAL
hypoxia and ischemia are the most common conditions leading to development of serious arrhythmias and to a decrease in cardiac contractility. During myocardial hypoxia and ischemia, action potential shortening is an early and common finding in cardiac membrane potential changes, and would limit the amount of Ca2+-influx through the Ca2+ channels during activity and decrease the tension development of the myocardium. With respect to the electrical activity observed during myocardial hypoxia and metabolic inhibition, Trautwein et al.1) were the first to report shortening of the action potential duration (APD) as the most prominent and consistent finding. Subsequently, MacDonald and MacLeod2) described the restoration of APD shortening by application of high external glucose or by intervention to increase intracellular ATP during hypoxia and metabolic inhibition. This is the first indication that the metabolic state of cardiac cells directly modulates APD possibly through an action on ionic channels. The shortening of APD was then attributed to a decrease in the inward Ca2+ current, increases in the background K+ currents, or both.3) Using the voltage clamp technique in small multicellular preparations, Vleugels, Vereecke and Carmeliet4) have demonstrated the appearance of the time-independent K+ current with little decrease in the Ca2+ current during hypoxia, which is thought to be the main ionic mechanism for APD shortening. A similar current could be induced by application of the metabolic inhibitor DNP and cyanide to various cardiac preparations5,6). Furthermore, intracellular injection of ATP restored shortened APD7). These findings have received strong support due to the discovery of ATP-sensitive K+ channels in cardiac cells by Noma8). In this review, I will discuss the pathophysiological function of this channel opening during myocardial ischemia.
PROPERTIES OF CARAIAC ATP-SENSITIVE K+ CHANNELS
ATP-sensitive K+ channels (KATP) are ligand-gated channels with a strong inhibition of channel activity by internal ATP and belong to the family of inward rectifier K+ channels. [8] [9] [10] [11] [12] [13] [14] The molecular structure of KATP also belongs to the family of inward rectifier K+ channels with two transmembrane spanning regions and the channel function can only be expressed by co-assembly with the channel protein (Kir 6.2) and the sulfonylurea receptor.15) KATP in the heart is characterized as being highly selective for K+, having a weak inward rectification and being the second largest single channel conductance among various K+ channels so far identified10-14) With symmetrical K+ concentrations (140mM) on both sides of the patch membrane, the conductance of the unitary inward current through KATP ranges between 70 and 90pS, which is smaller than that of Na+-activated K+ channels but larger than those of the inward rectifier, delayed rectifier, acetyl- Figure 1 ). This action becomes evident only at stimulatory activity.23,24,30,31,38,39) There are two ATP binding sites on the channel protein, one of which has a high binding affinity for ADP than ATP, although the ATP-bound form exhibits stronger channel inhibition than the ADP-bound form. Thus, channel inhibition by ATP is decreased because of decreased ATP binding and the potency order for the channel inhibition by ATP over ADP12, 14, 23, 24) ; ADP antagonizes the ATP inhibition of channel activity . There may be an additional mechanism involved in ADP stimulation . The second action by ADP is to restore channel activity , and this action is commonly shared by other nucleoside diphosphates such as UDP, GDP , CDP, and IDP. 23, 39) In the absence of ATP, nucleoside diphosphates can stimulate channel activity , or even after rundown, channel activity recovers with nucleoside diphosphates and Mg2+ . After restoration of channel activity by nucleoside diphosphates , KATP can be inhibited by ATP, as is the case during spontaneous opening . Thus, ADP-restored channel activity has no antagonism against ATP inhibition . There is some evidence that activation of KATP is coupled to a G-protein mediated process .40) Adenosine, which is increased in tissue and coronary blood during myocardial ischemia binds to the A1-receptor of the myocardial membrane . Activation of the A1-receptor by adenosine has been shown to activate KATP via an inhibitory Gprotein (Gi) coupled mechanism at the single channel recording in the cell-free condition, possibly through antagonizing ATP-induced inhibition . [41] [42] [43] 
HYPOXIC OR ANOXIC CONDITIONS COULD INDUCE ACTIVATION OF THE ATP-SENSITIVE K+ CHANNELS IN CARDIAC MYOCYTES
Hypoxic interventions and metabolic inhibitions could cause activation of the time-independent K+ current,4-7) which would cause shortening of APD, K+-efflux and extracellular K+ accumulation in early ischemia.62) The next question is whether hypoxic and anoxic interventions could induce activation of a specific K+ channel or K+ transport mechanism. If the former is the case, the opening of KATP exclusively or other types of K+ channel, as well, is involved in the increase in the outward current. There are other types of K+ channels besides KATP , which might open under ischemic conditions. They are the internal Na+ activated K+ channel63) and two types of K+ channels activated by arachidonic acid,64) since ischemic conditions could cause the accumulation of intracellular Na+ and arachidonic acid metabolites. In multicellular preparations and single isolated myocytes, ischemic or hypoxic interventions could produce shortening of APD and accumulation of K+ in the extracellular space without a concomitant increase in co-or counter-transported ions. These effects were abolished by glibenclamide, a specific blocker of KATP, suggesting the KATP channel might be a main contributor to these changes.65-70) The activated current is a potassium current which has properties similar to KATP in terms of conductance, kinetics and pharmacological responses to sulfonylurea compounds.67-70) There have been no reports thus for describing the opening or activation of other types of K+ channels besides KATP under these experimental settings. Benndorf et al,71) using a specific chamber to expose myocytes to anoxia (PO2<0.1Torr), demonstrated that only KATP was opened under this condition and that the channel opening was caused by a sufficient decrease in submembrane ATP levels. We also ob- served similar channel opening in cell-attached patch recordings from guinea-pig ventricular myocytes subjected to hypoxia without glucose plus 2-deoxyglucose (5mM) to block glycolysis ( Figure 3 ).73) Therefore, KATP is the main and only K+ channel to be opened during hypoxic and anoxic conditions in living cells. Despite accumulating evidence indicating the opening of KATP during early ischemia or at the time when APD is shortened under these conditions, the mechanism by which the current is activated is a matter of controversy since the measured [ATP]i is still at or near normal levels of around 5mM, [25] [26] [27] presence of ADP and with a low pH was examined. It was observed that the open probability of KATP at 2mM-ATP with ADP and pH 6 .8 was >1%, which is well above the level to activate the current causing APD shortening to 50% of the control, whereas the channel open probability in the patches without tryptic treatment was nearly zero at 2mM ATP and pH 7.2.73) In advanced stages of ischemia, intrinsic properties of KATP regarding the closure by ATPi might be altered due to Ca2+-dependent process giving persistent channel activity in the presence of ATP. 74) The APD shortening observed during early ischemia and hypoxia appears to be caused mostly by the opening of KATP , because of the magnitude of the current activation and the sensitivity to glibenclamide.67,69-71) As for the mecha-nism of K+ loss from ischemic or hypoxic myocardium, however, the evidence supporting KATP channel opening as the main factor is somewhat controversial. Pretreatment with KATP channel blockers reduces K+ loss in hypoxia or from ischemic myocardium, [65] [66] [67] 70, 75, 76) , and therefore, extracellular K+ accumulation in early ischemia is attenuated but not completely attenuated depending on the experimental design. 62, 76) In the presence of K+ channel openers, the rate of increase in [K+]0 is not enhanced,77-79, see also 62) suggesting that the opening of KATP is not a major factor responsible for increased K+ efflux. There may be additional factor(s) involved in K+ efflux and external K+ accumulation in ischemic myocardium.
ROLE OF KATP OPENING IN ISCHEMIA/REPERFUSION
It is well known that there are various types of arrhythmias developed during myocardial ischemia. The types and mechanism of these ischemia-induced arrhythmias differ depending on time after onset of ischemia, and differ in different experimental models and species used.80) During early ischemia within 30 minutes of its onset, ventricular fibrillation and ventricular tachycardias are major arrhythmias and causes of fatal events. These fatal arrhythmias are due to reentry.80) It has also been suggested that premature beats during early ischemia are mostly caused by reentry.81) The opening of KATP during an ischemic period could lead to a shortening of APD and partly increased extracellular K+ accumulation. The former condition can be beneficial, on the one hand, for cardiac function since the shortened APD limits the Ca2+-influx during activity to decrease tension development and thereby to decrease energy consumption. On the other hand, shortening of APD and extracellular K+ accumulation leading to a shortened refractory period, development of slowing in conduction and block are the main factors predisposing reentry and serious arrhythmias in the early phase of ischemia,62,80) since epicardial cells are more susceptible than endocardial cells for APD shortening and KATP in the former is more sensitive to metabolic inhibition for its opening than that in the latter,82) the heterogenous appearance of these conditions enable easy development of reentry. Pretreatment with KATP blockers prevents APD shortening, attenuates K+ accumulation to some extent, and decreases or improves conduction slowing and block. As a result, the development or incidence of serious arrhythmias during early ischemia can be reduced by the application of sulfonylurea drugs. 65, 66, 72, [75] [76] [77] [78] 83) Additional activation of KATP in acute ischemia may enhance the rate of APD shortening and adversely affect the incidence of serious ventricular arrhythmias. 62, 83) In addition to these direct electrophysiological effects, KATP channel modulation can affect several factors that influence the development of arrhythmias. Application of KCOs delays the onset of ischemic contracture, postpones the occurrence of electrical uncoupling and abbreviates irreversible cell injury.71,84-89) Eventually, infarct size is reduced by application of KCOs in dogs,85,88-91) although conflicting results have been reported.93,94) Glibenclamide, a KATP blocker, shortened the development of ischemic contracture and irreversible damage, [84] [85] [86] [87] [88] [89] [90] [91] [92] which supports the cardioprotective effect of KATP channel activation, while conflicting results have also been presented depending on the experimental conditions and animal models used (Table) .
Recent evidence supports the notion that the opening of KATP mimicks the effect of ischemic preconditioning; a brief ischemic event protects cellular damage and reduces infarct size in subsequent, more severe ischemic insult.95) The cardioprotection by the KATP opening is provided by abolition of the effects of ischemic preconditioning by pretreatment with glibenclamide or 5-hydroxydecanoate, and by tolerance to subsequent ischemia achieved with the application of KCOs96-99) It is hypothesized, therefore, that the activation of KATP is involved in mediating ischemic preconditioning, although somewhat conflicting results against this cardioprotective effect by channel activation have been presented in different experimental models.100-102) Cardioprotection by KCOs appears to be independent from their peripheral vasodilatory action and depends on a direct action on the myocardium. Despite their diverse chemical structures, the cardioprotective effects of KCOs are uniformly observed. Different types of KATP blockers can equally abolish this cardioprotection, which supports the involvement of KATP opening in this process. The exact mechanism of cardioprotection afforded by KATP activation is not known. One explanation is that opening the channels during the proceeding ischemia causes shortening of APD and limits Ca2+-influx during activity, which decreases tension development, abbreviates energy consumption, and results in elimination of Ca2+-overload in myocardial cells. It has been shown that the effects of preconditioning associated with KATP activation are associated with energy preservation during ischemia and reperfusion,103) while again an unfavourable result without increased high energy phosphate content is presented in rat hearts.104) Most of these supporting data for KATP opening in cardioprotection have shown improved mechanical function on reperfusion, reduced infarct size and cell damage. As to the beneficial or inhibiting effects on reperfusion arrhythmias, studies are limited , 87, 92, 103, 105) and poor results have been reported.104,106-108) The major supporting, opposing and inconclusive data with respect to the involvement of KATP activation in various types of cardioprotection with different models depending on animal species are listed in the Table. The other major hypothesis attributed to the involvement in ischemic preconditioning is activation of A1 adenosine receptors as an initiating mechanism Table. KATP shown to activate KATP via a G-protein coupled mechanism. [41] [42] [43] A link between A1 receptor activation and KATP channel opening in ischemic preconditioning has been suggested. Whether the two factors are located in the same line of the process involved in ischemic preconditionig or not has not been clarified. Additional factors such as muscarinic receptors, G-protein coupled mechanism, activation of protein kinase C and others have been implicated in ischemic preconditioning using different experimental approaches, models and animal species.111)
It is not known whether their actual roles and the interrelations among these factors involved in initiation and development, or if KATP activation is serving as an end effector of ischemic preconditioning.116) Further studies are necessary to elucidate the actual mechanism, including at the molecular levels, involved in this very important cardioprotective action.
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